Novavax Inc (NVAX)
234.00
+2.77 +1.20%
NASDAQ
Mar 1, 16:59
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 204.76M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -5.22 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -272.52M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -125.7% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0% |
| Price and Valuation | |
| Market Cap | 15.74B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 55.06 |
| PE Ratio | -- |
| Price to Book Value | 147.87 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 3.022 |
| Free Cash Flow (Quarterly) | -15.22M |
| Return on Equity | Upgrade |
View All NVAX News
News
-
WireHeadlineTime (ET)
-
Yahoo03/01 19:17
-
Yahoo03/01 18:04
-
Yahoo03/01 17:48
-
Yahoo03/01 16:41
-
SA Breaking News03/01 16:32
-
Yahoo03/01 16:31
-
Yahoo03/01 16:28
-
Yahoo03/01 16:20
-
Yahoo03/01 16:20
-
MT Newswires03/01 16:16
-
Yahoo03/01 16:16
-
Yahoo03/01 16:06
-
SA Breaking News03/01 16:06
-
MT Newswires03/01 16:03
-
Yahoo03/01 16:03
-
Globe Newswire03/01 16:02
-
Yahoo03/01 14:58
-
Yahoo03/01 14:30
-
Yahoo03/01 13:45
-
Yahoo03/01 11:07
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 03/01/2021 | Earnings | Novavax Inc Fourth Quarter Earnings Result for 2020 |
| 03/01/2021 16:30 EST | Misc | Novavax Inc Fourth Quarter Earnings Conference Call for 2020 |
| 11/09/2020 | Earnings | Novavax Inc Third Quarter Earnings Result for 2020 |
| 11/09/2020 16:30 EST | Misc | Novavax Inc Third Quarter Earnings Conference Call for 2020 |
| 08/10/2020 16:30 EDT | Misc | Novavax Inc Second Quarter Earnings Conference Call for 2020 |
| 08/10/2020 | Earnings | Novavax Inc Second Quarter Earnings Result for 2020 |
| 06/25/2020 08:30 EDT | Misc | Novavax Inc Annual General Meeting for 2019 |
| 05/11/2020 16:30 EDT | Misc | Novavax Inc First Quarter Earnings Conference Call for 2020 |
| 05/11/2020 | Earnings | Novavax Inc First Quarter Earnings Result for 2020 |
| 03/11/2020 16:30 EDT | Misc | Novavax Inc Fourth Quarter Earnings Conference Call for 2019 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: https://www.novavax.com
- Investor Relations URL: http://ir.novavax.com/phoenix.zhtml?c=71178&p=irol-irhome
- HQ State/Province: Maryland
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Mid Cap/Growth
- Next Earnings Release: Mar. 01, 2021
- Last Earnings Release: Mar. 01, 2021
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. Novavax develops product candidates geared toward all age demographics of the general population.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 234.00 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| BBH | VanEck Vectors Biotech ETF | 5.12% |
| FRBRX | Franklin Biotechnology Discovery R6 | 3.32% |
| XBI | SPDR® S&P Biotech ETF | 1.54% |
| FIJYX | Fidelity Advisor® Biotechnology Z | 1.26% |
| IBB | iShares Nasdaq Biotechnology ETF | 1.21% |
| IWN | iShares Russell 2000 Value ETF | 0.73% |
| SWSSX | Schwab Small Cap Index | 0.52% |
| IWM | iShares Russell 2000 ETF | 0.49% |
| VISVX | Vanguard Small Cap Value Index Inv | 0.45% |
| VBR | Vanguard Small-Cap Value ETF | 0.45% |
| NAESX | Vanguard Small Cap Index Inv | 0.29% |
| FSSNX | Fidelity® Small Cap Index | 0.26% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- NVAX Tweets Stocktwits
Advertisement
